• BX Home
  • Business of Biotechnology: Blog [Page 11]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

BUSINESS OF BIOTECHNOLOGY

They're perfecting scientific developments that could cure the world's toughest diseases, improve food production, and even yield energy alternatives. This is the exciting world of biotechnology, where young companies fight to make innovative discoveries -- and to find new and innovative ways of funding those innovations.

Business of Biotechnology is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 1,249 news and 4,710 blog items. Read updated news, blogs, and resources about Business of Biotechnology. Find user-submitted articles and reactions on Business of Biotechnology from like-minded professionals.

Blogs

Recent blog posts on this topic.

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Chimerix, Omthera enter price ranges for expected biotech IPOsmore

Two biotech players offered price ranges for their hoped-for initial public offerings, Renaissance Capital reported.

Clavis preps endgame after final PhIII cancer drug failuremore

Clavis Pharmaceuticals shares flat-lined at about 18 cents this morning as the Norwegian biotech company outlined a...

Next-gen Botox developer Revance raises $33M to wrap PhIII effortmore

Botox had better watch out. Another next-gen cosmetic therapy gunning to offer a simpler replacement for the temporary...

Karolinska portfolio biotech says PhII lung cancer drug on promising t...more

An early snapshot of preliminary data from a midstage study of an experimental lung cancer drug at a Karolinska...

Analysis: No quick fix in sight for AstraZeneca's PhIII woesmore

Today's Telegraph gives AstraZeneca ($AZN) a rousing hurrah today in a lengthy piece, noting that its plans to build a...

PolyMedix defaults and hands over a PhII antibiotic to bankruptcy cour...more

The small, struggling PolyMedix ($PYMX) has thrown in the towel and handed over the company to a bankruptcy court.

New Journal of Commercial Biotechnology issuemore

Copyright © thinkBiotech Journal of Commercial Biotechnology Vol 19, Issue 2 (2013) Capturing Value G.

Daiichi Sankyo ditches cancer drug program from ArQulemore

After a pair of trial setbacks with a separate program from ArQule, Japan-based drugmaker Daiichi Sankyo has decided to...

Biotech M&A deals dominate key Q1 metricmore

The analysts at Thomson Reuters have been crunching the numbers and found that the life sciences industry produced the...

BioCryst's shares spike on hope that flu drug can rise from the gravemore

Months after the beleaguered BioCryst Pharmaceuticals ($BCRX) started reading the last rites for its long-running Phase...

Drug Patent Expirations for Mar 12 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 22 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 25 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 26 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

A Patient Centric Commercial Model for Cancer Caremore

Copyright © thinkBiotech Cancer is one of the most challenging diseases of all - not only in terms of the clinical...

The funding ecosystem of early-stage biotechnology firms and its misal...more

Copyright © thinkBiotech The development and commercialization of new therapeutics have had immense impact on the...

Should the HHS Decision to Overrule FDA on Plan B Be Reversedmore

Copyright © thinkBiotech On December 7, 2011, Secretary of Health and Human Services Kathleen Sebelius overruled a...

Challenges and prospects for monoclonal antibodies in Chinamore

Copyright © thinkBiotech The technology of monoclonal antibodies has been developed since the 1990s and is attracting...

Getting Social with Biotechnology Business Developmentmore

Copyright © thinkBiotech Social media is becoming increasingly important in business. While the lack of regulations...

Drug Patent Expirations for Mar 22 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 25 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 12 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 22 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Drug Patent Expirations for Mar 25 2013more

Copyright © thinkBiotech If your reader cannot render the information below, go to http://www.DrugPatentWatch.

Top Sources: Business of Biotechnology

  • Biotech Blog
  • News
  • Health Beat
  • frontendofinnovation.blogspot.com
  • Nature Biotechnology
  • The Biotech Weblog
  • policyinnovations.org
  • Science Progress
  • LinkedIn Answers: Technology
  • World Pharma News / Published News

Most Active Users in this Topic

see all contributors in Business of Biotechnology

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: May 8
SOFTWARE ENGINEER at exciting biotech company! Adaptive Biotechnologies | Seattle, WA
Posted: Apr 19
Chief Medical Officer (CMO) for Pharma/Biotech Epc Search International | North Carolina
Posted: Apr 18
Biotech Director of Pipeline Marketing Alpine Group | Denver, CO
Posted: May 6
Biotech Sales Specialist II - Philadelphia Medimmune | Pennsylvania
Posted: May 18

Report comment contains invalid characters. ()
cancel
Search Cancel